CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy trial for rare heart condition halted before it began
Disease control TerminatedThis study was designed to test a new gene therapy called ASP2016 for heart problems in people with Friedreich Ataxia, a rare genetic disease that affects movement and the heart. The goal was to see if the treatment was safe and tolerable. However, the study was withdrawn before …
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
Weight-Loss drug semaglutide could be key to treating Obesity-Linked heart failure
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether aggressive weight loss using semaglutide can improve symptoms in people with a specific type of heart failure linked to obesity. About 81 participants with a BMI of 30 or higher will receive either semaglutide or a placebo. The main goal is to measure …
Matched conditions: CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 01, 2026 16:37 UTC